Chief Executive?magazine today announced Dave Ricks, CEO of Eli Lilly and Company, has been named 2025 Chief Executive of the Year by his peer CEOs. Ricks was selected by an independent committee of ...

Novartis is thriving with double-digit growth, driven by key drugs in oncology, cardiology, immunology, and neurology. See ...

Pharma stocks face tariff threats as Trump eyes shifting drug production to the U.S. Learn how companies plan to mitigate ...

In this week’s episode of "The Top Line," Fierce Biotech’s Gabrielle Masson and Darren Incorvaia sit down to discuss a recent ...

Several pharma CEOs met with Chinese President Xi Jinping in Beijing. President Donald Trump's reciprocal tariffs have mostly ...

Health care stocks have outperformed so far in 2025 despite uncertainty surrounding the new Donald Trump administration. Health care stocks can often be a solid defensive play in an uncertain economy.

The group had a bad week after turmoil at the FDA, continuing a long period of underperformance following the pandemic.

Novo Nordisk is licensing a drug called LX9851 from Lexicon Pharmaceuticals for up to $75 million in upfront and near-term ...

Biotech stocks toppled early Thursday after Trump announced broad global tariffs, including a 20% tariff on goods from Europe ...

The fear of a trade war over pharmaceuticals between the EU and the US has been avoided for now, but the European Commission ...

As US President Donald Trump takes aim at the mostly American-owned pharmaceutical factories that dot the Irish countryside, ...

The Trump administration carved out an exception for pharmaceuticals from the president's new tariff regime, at least for now ...